Abstract
When medication management no longer allows for consistent control of motor symptoms in PD because of the development of motor fluctuations and dyskinesia, deep brain stimulation (DBS) therapy of the subthalamic nucleus or globus pallidus has been shown to improve on time, reduce dyskinesia, and improve quality of life. Appropriate patient selection is essential for a positive outcome. Various neurostimulator system options and surgical implantation approaches/methods now exist allowing for a more individualized approach. Optimization of DBS settings is largely dictated by a trial and error approach. Antiparkinsonian medications can often be reduced after DBS. Although the motor improvement after DBS can be dramatic, non-motor PD symptoms are not well treated with current forms of stimulation and require ongoing management. Additionally, axial motor symptoms including freezing of gait and postural instability are often refractory to DBS and remain a treatment challenge.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362(22):2077–91.
Hariz MI. Complications of deep brain stimulation surgery. Mov Disord Off J Mov Disord Soc. 2002;17(Suppl 3):S162–6.
Marks WJ Jr, editor. Deep brain stimulation management. Cambridge: Cambridge University Press; 2015.
Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 2013;12(1):37–44.
Okun MS, Fernandez HH, Wu SS, Kirsch-Darrow L, Bowers D, Bova F, et al. Cognition and mood in Parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol. 2009;65(5):586–95.
Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, et al. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease. J Neurosurg. 2016;124(4):908–16. Epub 2015/10/27.
Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med. 2013;368(7):610–22.
St George RJ, Nutt JG, Burchiel KJ, Horak FB. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology. 2010;75(14):1292–9. Epub 2010/10/06.
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ Jr, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63–73.
Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9(6):581–91.
Williams NR, Foote KD, Okun MS. STN vs. GPi deep brain stimulation: translating the rematch into clinical practice. Mov Disord Clin Pract (Hoboken). 2014;1(1):24–35.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ostrem, J.L. (2019). Deep Brain Stimulation for Fluctuations and Dyskinesia in Parkinson’s Disease. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-97897-0_6
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-319-97896-3
Online ISBN: 978-3-319-97897-0
eBook Packages: MedicineMedicine (R0)